Other segment revenue — Operating Income (Loss)
Idexx Laboratories Other segment revenue — Operating Income (Loss) increased by 832.7% to $2.31M in Q3 2024 compared to the prior quarter. Year-over-year, this metric grew by 386.3%, from -$808.00K to $2.31M. Over 2 years (FY 2021 to FY 2023), Other segment revenue — Operating Income (Loss) shows a downward trend with a -92.8% CAGR. This is a positive signal — higher values indicate stronger performance for this metric.
Analysis
How to read this metric
An increase in operating income indicates that secondary business lines are becoming more efficient or profitable, whereas a widening loss may signal high investment costs or poor performance in these areas.
Detailed definition
This metric measures the operating profitability or loss generated specifically by the company's 'Other' business segmen...
Peer comparison
Similar to other firms' 'Other' segment operating results, which often fluctuate based on R&D spending or the maturity phase of new business initiatives.
idxx_segment_other_segment_revenue_operating_income_lossHistorical Data
| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $422.00K | $2.82M | $4.86M | $1.83M | $1.39M | -$1.03M | $3.30M | $370.00K | -$1.14M | -$808.00K | $1.65M | -$1.03M | $248.00K | $2.31M |
| QoQ Change | — | +567.3% | +72.4% | -62.4% | -24.0% | -174.1% | +420.4% | -88.8% | -407.0% | +28.9% | +303.8% | -162.8% | +124.0% | +832.7% |
| YoY Change | — | — | — | — | +229.4% | -136.6% | -32.0% | -79.8% | -181.7% | +21.6% | -50.1% | -379.5% | +121.8% | +386.3% |
Similar Metrics at Other Companies
Frequently Asked Questions
- What is Idexx Laboratories's other segment revenue — operating income (loss)?
- Idexx Laboratories (IDXX) reported other segment revenue — operating income (loss) of $2.31M in Q3 2024.
- How has Idexx Laboratories's other segment revenue — operating income (loss) changed year-over-year?
- Idexx Laboratories's other segment revenue — operating income (loss) increased by 386.3% year-over-year, from -$808.00K to $2.31M.
- What is the long-term trend for Idexx Laboratories's other segment revenue — operating income (loss)?
- Over 2 years (2021 to 2023), Idexx Laboratories's other segment revenue — operating income (loss) has grown at a -92.8% compound annual growth rate (CAGR), from $13.93M to $73.00K.
- What does other segment revenue — operating income (loss) mean?
- The operating profit or loss generated by the company's secondary or non-core business segments.